Results: Colorectal Cancer

Results from Abstracts

Pick one of the followings

*Some genes may be words of complete meaning. In any case, if present, they are relevant key words.

Legend:

***	p-value <= 0.001
**	p-value <= 0.01
*	p-value <= 0.05
n.s.	not significant

Top Ranked Genes, Molecules or Short Names*

Kras ***
Hr **
Braf **
Apc **
Egfr *
Runx3 *
Nr1h2 *
Trip6 *
Kiaa0125 *
Dab2ip *
Mief1 *
Pold1 *
Foxq1 *
Btg3 *
Atg4b *
Inpp4b *
Sstr2 *
Nos2 *
Dld *
Spg20 *
Cck *
Cd69 *
Orai1 *
Birc2 *
Cxcl2 *
G6pd *
Pms2 *
Gcg *
Ppbp *
Mlh1 *
Hgd *
Strap *
Casp3 n.s.
Sfrp1 n.s.
Pik3r1 n.s.
Chek1 n.s.
Sfrp2 n.s.
Cxcl9 n.s.
Mettl3 n.s.
Dclk1 n.s.
Ccr2 n.s.
Fap n.s.
Msh2 n.s.
Dcc n.s.
Tigit n.s.
Ttr n.s.
Vegfc n.s.
Lars n.s.
Mmp3 n.s.
Ccnb1 n.s.
Klf4 n.s.
Myb n.s.
Msh6 n.s.
Tgfbr2 n.s.
Nqo1 n.s.
Atg12 n.s.
Yap1 n.s.
Cxcl10 n.s.
Twist1 n.s.
Msh3 n.s.
Esd n.s.
Tcf7l2 n.s.
Fh n.s.
Ugt1a1 n.s.
Top2a n.s.
Cs n.s.
Stat3 n.s.
Eno1 n.s.
Pik3ca n.s.
Sry n.s.
Ccnd1 n.s.
Gata3 n.s.
Foxp3 n.s.
Bax n.s.
Ran n.s.
Dnmt3b n.s.
Malat1 n.s.
Cxcl1 n.s.
Cxcl3 n.s.
Kit n.s.
Foxm1 n.s.
Mut n.s.
Kir2ds4 n.s.
Zmat3 n.s.
Crb3 n.s.
Ezh2 n.s.
Zeb1 n.s.
Tp53 n.s.
Ptn n.s.
Rnf43 n.s.
Cldn8 n.s.
Sox8 n.s.
Ptbp2 n.s.
Nln n.s.
Pcbd2 n.s.
Bag3 n.s.
Znf143 n.s.
Pole n.s.
Eif4a2 n.s.
Usp6nl n.s.

Top Ranked Key Phrases

Epidermal growth factor receptor egfr ***
Epithelial mesenchymal transition emt ***
Cancer genome atlas tcga ***
Human colorectal cancer cells ***
Metastatic colorectal cancer mcrc ***
Inflammatory bowel disease ibd ***
Disease free survival dfs ***
Progression free survival pfs ***
Colorectal cancer crc screening ***
Epithelial mesenchymal transition ***
Colorectal cancer crc patients ***
Long term outcomes ***
Microsatellite instability msi ***
Cell cycle arrest ***
Log rank test ***
Body mass index ***
Inflammatory bowel disease ***
Human colorectal cancer ***
Metastatic colorectal cancer ***
Lymph node metastasis ***
Anti egfr therapy ***
Adjacent normal tissues ***
Disease free survival **
Crc cell lines **
Lynch syndrome ls **
Real time pcr **
Braf v600e mutation **
Including colorectal cancer **
Wnt Β catenin pathway **
Pd l1 expression **
Colorectal cancer cells **
Immune checkpoint inhibitors **
Advanced colorectal cancer **
Progression free survival **
Colorectal cancer screening **
Independent prognostic factor **
Colorectal cancer tissues **
Developing colorectal cancer **
Colon cancer cells **
Cancer related death **
Cancer related deaths **
Cell cycle progression **
Independent risk factor **
Overall survival os **
95% confidence intervals cis **
Crc cell proliferation **
Colorectal cancer crc **
Colorectal cancer risk **
Western blot analysis **
Colorectal cancer treatment **
Potential therapeutic target **
Present study was **
Colorectal cancer patients **
Retrospective cohort study **
Colon cancer patients *
Rectal cancer patients *
Crc tissues compared *
Second leading cause *
95% confidence interval ci *
Cell lines *
Bowel preparation *
Sw480 cells *
Pd l1 n.s.
Adverse events n.s.
Present study aimed n.s.
T cells n.s.
Odds ratio n.s.
Cell cycle n.s.
Signaling pathways n.s.
Multivariable analysis n.s.
Significantly lower n.s.
Metastatic disease n.s.
Self renewal n.s.
Decision making n.s.
Generation sequencing n.s.
Significantly higher n.s.
Statistically significant n.s.
Cell proliferation n.s.
Qrt pcr n.s.
Liquid biopsy n.s.
Colorectal cancer n.s.
Significantly increased n.s.
Dna methylation n.s.
Primary care n.s.
Tumor suppressor n.s.
Significantly different n.s.
Peripheral blood n.s.
Cell viability n.s.
E cadherin n.s.
Lynch syndrome n.s.
Significantly correlated n.s.
Vitamin d n.s.
Mouse model n.s.
Metabolic syndrome n.s.
Primary tumor n.s.
Fezf1 as1 n.s.
Cell death n.s.
Tumor cells n.s.
Normal cells n.s.
Immune cells n.s.

Top Ranked Mesh Terms

Colorectal neoplasms ***
Middle aged **
Aged *
Adenocarcinoma *
Mitogen-activated protein kinase 3 *
Mitogen-activated protein kinase 1 *
Pathology *
Indocyanine green *
Intracellular signaling peptides and proteins *
Anastomosis surgical *
Operative time *
Clinical protocols *
Retrospective studies *
Yttrium radioisotopes *
Lymphocyte count *
Adenomatous polyposis coli *
Leucovorin *
Survival rate *
Rna small interfering *
Cpg islands *
Mice nude *
Hepatectomy *
Ligation *
Early detection of cancer *
Organoids *
Male *
United kingdom *
Perioperative care *
Cholecalciferol *
Oncogenes *
Fluorouracil *
Neoplasm staging *
Proportional hazards models *
Proto-oncogene proteins p21 *
Vitamins *
Cell line tumor *
Survival analysis *
Intestines *
Antineoplastic agents *
Colon *
Biomarkers tumor *
Uterine cervical neoplasms *
Disease progression *
Postoperative complications *
Protein-serine-threonine kinases *
Asian continental ancestry group n.s.
Neoplasm invasiveness n.s.
Killer cells natural n.s.
Ras proteins n.s.
United states n.s.
Vitamin d n.s.
Rectal neoplasms n.s.
Liver neoplasms n.s.
Biosensing techniques n.s.
Aged 80 and over n.s.
Risk factors n.s.
Fluorescent dyes n.s.
Female n.s.
Occult blood n.s.
Erbb receptors n.s.
Chemotherapy adjuvant n.s.
Treatment outcome n.s.
Carcinogenesis n.s.
Prognosis n.s.
Laparoscopy n.s.
Colonic neoplasms n.s.
Cetuximab n.s.
Neoplastic stem cells n.s.
Neoadjuvant therapy n.s.
Colorectal neoplasms hereditary nonpolyposis n.s.
Datasets as topic n.s.
Quality of life n.s.
Dna methylation n.s.
Embolization therapeutic n.s.
Adenomatous polyposis coli protein n.s.
Wnt signaling pathway n.s.
Colonoscopy n.s.
Mortality n.s.
Microsatellite instability n.s.
Colectomy n.s.
Mass screening n.s.
Cell movement n.s.
Dietary supplements n.s.
Pharmacokinetics n.s.
Hct116 cells n.s.
Lymphatic metastasis n.s.
Ht29 cells n.s.
Randomized controlled trials as topic n.s.
Tumor cells cultured n.s.
Drug therapy n.s.
Pedigree n.s.
Lung neoplasms n.s.
Cell proliferation n.s.
Neoplasm recurrence local n.s.
Neoplasm metastasis n.s.
Case-control studies n.s.
Rna long noncoding n.s.
Gene expression regulation neoplastic n.s.
Double-blind method n.s.
Humans n.s.

Results for: Colorectal Cancer

Results from Abstracts

KEGG Pathways

Gene Ontology Biological Processes